Brief: Pasithea Therapeutics Adds Esketamine Nasal Spray To Its Clinic Offerings In The U.K.
23/11/2021 13:32
Nov 23 (Reuters) - Pasithea Therapeutics Corp KTTA.O :
* PASITHEA THERAPEUTICS ADDS ESKETAMINE NASAL SPRAY TO ITS
CLINIC
OFFERINGS IN THE U.K.
Source text for Eikon: ID:nGNXbnQG4d
Further company coverage: KTTA.O
(Reporting by Leroy Leo)
((Leroy.Dsouza@thomsonreuters.com;))
Recent news on Pasithea Therapeutics
See all newsPasithea Therapeutics Corp reports results for the quarter ended June 30 - Earnings Summary
Pasithea Therapeutics Corp expected to post a loss of 16 cents a share - Earnings Preview
Brief: Pasithea Therapeutics Announces Positive Interim Phase 1 Advanced Cancer Study Data
Brief: Pasithea Therapeutics Announces Closing Of $60 Million Public Offering Of Common Stock
Pasithea Therapeutics jumps after $60 million public offering announcement